Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
American Journal of Clinical Oncology: Cancer Clinical Trials is Scopus-indexed (Q3, CiteScore 2.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 0277-3732Verify ISSN ↗1537-453XVerify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 271 / 428 | 36th | Q3 |
| Cancer Research | 182 / 233 | 22nd | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1982–present, best quartile Q3, CiteScore 2.7.
American Journal of Clinical Oncology: Cancer Clinical Trials is Q3 in Oncology (rank 271 of 428) and Q4 in Cancer Research (rank 182 of 233), by CiteScore 2025.
American Journal of Clinical Oncology: Cancer Clinical Trials is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q3 at the 36th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.647, quartile Q3, with an H-index of 95.
American Journal of Clinical Oncology: Cancer Clinical Trials is published by Lippincott Williams and Wilkins. Its print ISSN is 0277-3732 and its online ISSN is 1537-453X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
American Journal of Clinical Oncology: Cancer Clinical Trials has an h-index of 111 and a 2-year mean of 1.5 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q3. On 2-year citations it ranks #244 of 424 Scopus journals in Oncology.
American Journal of Clinical Oncology: Cancer Clinical Trials published 126 papers in 2025; its busiest recent year was 2019 with 151. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from United States (56.2%), Pakistan (8.8%) and United Kingdom (7.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 3 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.